{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:30:04Z","timestamp":1770813004741,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jim.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:16:52Z","timestamp":1552565812000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity"],"prefix":"10.1016","volume":"468","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3743-8044","authenticated-orcid":false,"given":"Kevin","family":"Larimore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thom","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Badillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Zori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Zoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoling H.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jim.2019.03.004_bb0005","first-page":"S116","article-title":"Evaluation of multiple dosing regimens in phase 2 studies of \u2018rAvPAL-PEG\u2019 for control of blood phenylalanine levels in adults with phenylketonuria","volume":"38","author":"Adams","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jim.2019.03.004_bb0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jim.2019.03.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173269","article-title":"Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"12","author":"Bell","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2019.03.004_bb0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/14656566.2015.1013030","article-title":"Alternative therapies to address the unmet medical needs of patients with phenylketonuria","volume":"16","author":"Blau","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.jim.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/bj1730723","article-title":"Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio) propionate, a new heterobifunctional reagent","volume":"173","author":"Carlsson","year":"1978","journal-title":"Biochem. J."},{"key":"10.1016\/j.jim.2019.03.004_bb0030","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2298\/JSC140402065D","article-title":"Detection of a Trichinella-specific IgE in human trichinellosis \u2013 the creation of a new test","volume":"79","author":"Devi\u0107","year":"2014","journal-title":"J. Serb. Chem. Soc."},{"key":"10.1016\/j.jim.2019.03.004_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ebiom.2018.10.038","article-title":"Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials","volume":"37","author":"Gupta","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jim.2019.03.004_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2018.03.003","article-title":"Pegvaliase for the treatment of phenylketonuria: a pivotal, double-blind randomized discontinuation phase 3 clinical trial","volume":"124","author":"Harding","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jim.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0001-706X(01)00149-8","article-title":"A simple and quick method for enhanced detection of specific IgE in serum from lymphatic filariasis patients","volume":"80","author":"Jaoko","year":"2001","journal-title":"Acta Trop."},{"key":"10.1016\/j.jim.2019.03.004_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000024408","article-title":"Method for measuring specific IgE in sera by direct ELISA without interference by IgG competition or IgG autoantibodies to IgE","volume":"122","author":"Kadooka","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jim.2019.03.004_bb0055","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaci.2016.04.056","article-title":"Half-life of IgE in serum and skin: consequences for anti-IgE therapy in patients with allergic disease","volume":"139","author":"Lawrence","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0192623313510987","article-title":"Immunogenicity\/hypersensitivity of biologics","volume":"42","author":"Leach","year":"2014","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jim.2019.03.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2003.08.017","article-title":"Enhancement of murine IgE antibody detection by IgG removal","volume":"284","author":"Lehrer","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2019.03.004_bb0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-018-0858-7","article-title":"Long-term safety and efficacy of pegvaliase treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension","volume":"13","author":"Longo","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jim.2019.03.004_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.06.002","article-title":"Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products","volume":"289","author":"Mire-Sluis","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2019.03.004_bb0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000236731","article-title":"Binding properties of protein a and protein G for human IgE","volume":"104","author":"Peng","year":"1994","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jim.2019.03.004_bb0085","author":"Portnoy"},{"key":"10.1016\/j.jim.2019.03.004_bb0090","first-page":"1781","article-title":"Adverse drug reactions: types and treatment options","volume":"68","author":"Riedl","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jim.2019.03.004_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jim.2019.03.004_bb0100","series-title":"Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products, Guidance for Industry","author":"US Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.jim.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15476910490919140","article-title":"Detection of allergen-specific IgE antibody responses","volume":"1","author":"Wachholz","year":"2005","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.jim.2019.03.004_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpba.2013.06.005","article-title":"An electrochemiluminescence (ECL)-based assay for the specific detection of anti-drug antibodies of the IgE isotype","volume":"86","author":"Wu","year":"2013","journal-title":"J. Pharm. Biochem. Anal."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918302242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918302242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T12:44:37Z","timestamp":1554122677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175918302242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":22,"alternative-id":["S0022175918302242"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2019.03.004","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}